DJ AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slid 5.83% to $175.67 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.57% to 4,982.77 and Dow Jones Industrial Average falling 0.84% to 37,645.59.
This was the stock's sixth consecutive day of losses.
AbbVie Inc. closed 19.66% below its 52-week high of $218.66, which the company achieved on March 10th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.41% to $150.00, Pfizer Inc. $(PFE)$ fell 3.49% to $21.84, and Amgen Inc. $(AMGN)$ fell 3.26% to $280.26.
Trading volume (12.5 M) eclipsed its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 08, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.